Ristela, a plant-based product aimed at menopausal women that promises to increase sexual pleasure, was introduced on the women’s wellness website Bonafide a few weeks ago. Bonafide said that sales of Ristela in its first 10 days surpassed expectations for three months, and another menopause-focused product is planned for early next year.
At the Bloom Burton & Co. Healthcare Investor Conference in Toronto, which took place from April 30 to May 1, experts in the industry sat down for a panel discussion called “Investing in Commercial Stage Healthcare Companies.” They focused largely on drug price issues in the US, political implications for the industry and the struggles …
Oliva will be honored with the 2019 Hall of Fame Award from SJU’s Haub School of Business on April 9, 2019 at The Union League of Philadelphia. A proud SJU grad, Oliva has been a healthcare investor for over 20 years and focuses on commercial stage medical technology, healthcare service, and specialty pharmaceutical investments. You …
Pennsylvania’s life sciences industry honored its own Wednesday night as awards where handed out at Life Sciences Pennsylvania’s annual dinner. The event at the Pennsylvania Convention Center drew a record crowd of more than 1,300 people. Paul Touhey, Operating Partner at 1315 Capital awarded the John Nash MedTech Leadership Award.
With more than three decades in the pharmaceutical and biotechnology industries, Mary Fisher is a force to be reckoned with in aesthetics. Her CV includes leadership positions at Acorda Therapeutics, Cephalon, Immunex, and Boehringer Ingelheim.
Philadelphia Business Journal lists Adele Oliva as one of twelve women who are having an impact on bioscience
Innovative Health and Medline ReNewal are continuing their collaboration on a single-use device reprocessing program for hospitals. The two companies bring a growing portfolio of medical device reprocessing clearances. Medline ReNewal specializes in the medical/surgical space, and Innovative Health specializes in cardiology/electrophysiology devices.
Innovative Health announced on Monday that it scored FDA clearance to reprocess St. Jude Medical’s ViewFlex Xtra Diagnostic Ultrasound Catheter. “Reprocessing is changing,” Rick Ferreira, CEO of Innovative Health, told HCB News. “It used to be about mimicking manufacturer technique on low-complexity devices late in their life cycle. SUD reprocessing is increasingly about understanding clinical …
Easing adoption, accelerating commoditization and lowering costs. That’s how it works everywhere else. Why not in healthcare? In my interview of experts from Innovative Health, the largest U.S. medical device reprocessor specializing in cardiology, they all reinforced the same point: hospital decision-makers still must turn the tables on the manufacturer.
Adele is bringing the firm she co-founded, 1315 Capital, L.P., into the newest round for the cosmetics company that Mary spun off from SkinMedica. Colorescience raised $15-million in Series C financing in a round led by 1315.